Not yet recruiting
Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC
NCT06861777
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China